Pharma Mar Sau Stock Market Outlook
| PHMMF Stock | USD 88.72 1.84 2.03% |
Roughly 61% of Pharma Mar's investor base is looking to short. The analysis of overall sentiment of trading Pharma Mar SAU pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Pharma Mar's historical and current headlines, can help investors time the market. In addition, many technical investors use Pharma Mar SAU stock news signals to limit their universe of possible portfolio assets.
Comfort Level 39
Alarmed
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Pharma Mar's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Pharma Mar SAU.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentWaiting |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Pharma Mar SAU is 'Strong Hold'. Macroaxis provides Pharma Mar buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding PHMMF positions.
Execute Pharma Mar Advice
The Pharma recommendation should be used to complement the investment advice compiled from the current analysts' consensus on Pharma Mar SAU. Macroaxis does not own or have any residual interests in Pharma Mar SAU or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Pharma Mar's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Fair | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
For the selected time horizon Pharma Mar SAU has a Risk Adjusted Performance of (0.04), Jensen Alpha of (0.10), Total Risk Alpha of (0.21) and Treynor Ratio of (0.26)Macroaxis provides advice on Pharma Mar SAU to complement and cross-verify current analyst consensus on Pharma Mar SAU. Our recommendation engine determines the firm's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Pharma Mar is not overpriced, please check all Pharma Mar SAU fundamentals, including its ebitda, cash flow from operations, and the relationship between the price to book and total debt . Given that Pharma Mar SAU has a price to earning of 7.38 X, we recommend you to check out Pharma Mar SAU market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your recent risk tolerance and investing horizon.
Pharma Mar Trading Alerts and Improvement Suggestions
| About 27.0% of the company outstanding shares are owned by corporate insiders |
Pharma Mar Returns Distribution Density
The distribution of Pharma Mar's historical returns is an attempt to chart the uncertainty of Pharma Mar's future price movements. The chart of the probability distribution of Pharma Mar daily returns describes the distribution of returns around its average expected value. We use Pharma Mar SAU price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Pharma Mar returns is essential to provide solid investment analysis for Pharma Mar.
| Mean Return | -0.07 | Value At Risk | -0.12 | Potential Upside | 0.00 | Standard Deviation | 1.10 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Pharma Mar historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Pharma Mar Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Pharma Mar or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Pharma Mar's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Pharma pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.1 | |
β | Beta against Dow Jones | 0.29 | |
σ | Overall volatility | 0.67 | |
Ir | Information ratio | -0.15 |
Pharma Mar Volatility Alert
Pharma Mar SAU exhibits very low volatility with skewness of -3.12 and kurtosis of 31.32. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Pharma Mar's pink sheet risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Pharma Mar's pink sheet price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Pharma Mar Fundamentals Vs Peers
Comparing Pharma Mar's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Pharma Mar's direct or indirect competition across all of the common fundamentals between Pharma Mar and the related equities. This way, we can detect undervalued stocks with similar characteristics as Pharma Mar or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Pharma Mar's fundamental indicators could also be used in its relative valuation, which is a method of valuing Pharma Mar by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Pharma Mar to competition |
| Fundamentals | Pharma Mar | Peer Average |
| Return On Equity | 0.47 | -0.31 |
| Return On Asset | 0.13 | -0.14 |
| Profit Margin | 0.35 % | (1.27) % |
| Operating Margin | 0.33 % | (5.51) % |
| Current Valuation | 1.12 B | 16.62 B |
| Shares Outstanding | 18.09 M | 571.82 M |
| Shares Owned By Insiders | 26.95 % | 10.09 % |
| Shares Owned By Institutions | 10.48 % | 39.21 % |
| Price To Earning | 7.38 X | 28.72 X |
| Price To Book | 5.60 X | 9.51 X |
| Price To Sales | 5.57 X | 11.42 X |
| Revenue | 229.83 M | 9.43 B |
| Gross Profit | 213.39 M | 27.38 B |
| EBITDA | 104.08 M | 3.9 B |
| Net Income | 92.86 M | 570.98 M |
| Cash And Equivalents | 196.7 M | 2.7 B |
| Cash Per Share | 10.92 X | 5.01 X |
| Total Debt | 33.39 M | 5.32 B |
| Debt To Equity | 0.21 % | 48.70 % |
| Current Ratio | 2.86 X | 2.16 X |
| Book Value Per Share | 9.88 X | 1.93 K |
| Cash Flow From Operations | 25.68 M | 971.22 M |
| Earnings Per Share | 4.97 X | 3.12 X |
| Number Of Employees | 477 | 18.84 K |
| Beta | 0.12 | -0.15 |
| Market Capitalization | 1.26 B | 19.03 B |
| Total Asset | 368.39 M | 29.47 B |
| Retained Earnings | (17 M) | 9.33 B |
| Working Capital | 32 M | 1.48 B |
| Current Asset | 110 M | 9.34 B |
| Current Liabilities | 78 M | 7.9 B |
| Z Score | 22.2 | 8.72 |
| Annual Yield | 0.01 % |
Pharma Mar Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Pharma . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 88.72 | |||
| Day Typical Price | 88.72 | |||
| Price Action Indicator | (0.92) | |||
| Period Momentum Indicator | (1.84) |
About Pharma Mar Buy or Sell Advice
When is the right time to buy or sell Pharma Mar SAU? Buying financial instruments such as Pharma Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Pharma Mar in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Utilities Thematic Idea Now
Utilities
Highly leveraged corporations that deliver utilities such as power, water or gas to public or business. The Utilities theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Utilities Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Pharma Pink Sheet
Pharma Mar financial ratios help investors to determine whether Pharma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharma with respect to the benefits of owning Pharma Mar security.